2015 Oct 14:ajpregu.00536.2014. doi: 10.1152/ajpregu.00536.2014. [Epub ahead of print]
Abstract
The present study investigated the type 1 cannabinoid receptor (CB1R) as a potential candidate to mediate the homeostatic responses triggered by 24 hours of water deprivation (WD), which constitutes primarily a hydroelectrolytic challenge and also significantly impacts energy homeostasis. The present results demonstrated for the first time that CB1R mRNA expression is increased in the hypothalamus of WD rats. Furthermore, the administration of ACEA, a CB1R selective agonist, potentiated WD-induced dipsogenic effect, whereas AM251, a CB1R antagonist, attenuated not only water but also salt intake in response to WD. In parallel with the modulation of thirst and salt appetite, we confirmed that CB1Rs are essential for the development of appropriated neuroendocrine responses. Although the administration of ACEA or AM251 did not produce any effects on WD-induced vasopressin (AVP) secretion, oxytocin (OXT) plasma concentrations were significantly decreased in WD rats treated with ACEA. At the genomic level, ACEA significantly decreased AVP and OXT mRNA expression in the hypothalamus of WD rats, whereas AM251 potentiated both basal and WD-induced stimulatory effects on the transcription of AVP and OXT genes. In addition, we showed that WD alone upregulates proopiomelanocortin, Agouti-related protein, melanin-concentrating hormone and Orexin A mRNA levels in the hypothalamus, and that CB1Rs regulate main central peptidergic pathways controlling food intake, being most of these effects also significantly influenced by the hydration status. In conclusion, the present study demonstrated that CB1Rs participate in the homeostatic responses regulating fluid balance and energy homeostasis during WD.
Copyright © 2014, American Journal of Physiology – Regulatory, Integrative and Comparative Physiology.
Copyright © 2014, American Journal of Physiology – Regulatory, Integrative and Comparative Physiology.
KEYWORDS:
ACEA; AM251; Water deprivation; type 1 cannabinoid receptor
- PMID:
- 26468265
- [PubMed – as supplied by publisher]